FILE:CVS/CVS-8K-20070518163107.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
 
 
CVS Caremark Corporation is filing this Amendment No. 1 to its Current Report on Form 8-K filed with the Securities and Exchange Commission (the SEC) on February 13, 2007 to amend the item number under which the information was disclosed.  The Current Report is hereby amended to provide that the information previously filed under Item 8.01Other Events is amended and now furnished under Item 7.01Regulation FD Disclosure.
 
The information in the Current Report shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.  The information contained in the Current Report and in the accompanying exhibits shall be incorporated by reference into
the joint proxy statement/prospectus included in the Registration Statement on Form S-4, file No. 333-139470, filed by CVS Corporation with the SEC and declared effective by the SEC on January 19, 2007, and mailed by CVS and Caremark Rx, Inc. to their respective stockholders commencing on January 19, 2007.
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 


